中文
OUR RESEARCH AREA
What's monoclonal antibody (mAB)?
monoclonal antibody (mAB) ?A single type of antibody that is directed against a specific epitope (antigen, antigenic determinant) and is produced by a single clone of B cells or a single hybridoma cell line, which is formed by the fusion of a lymphocyte cell with a myeloma cell. Some myeloma cells synthesize single antibodies naturally.



[2010-2-5] CPGJ Selected to be Intellectual Property Pilot Unit
[2009-12-14] A new chapter in Biopharmaceuticals -The Collaboration between Chinese and Brazilian Pharmaceutical Enterprises
[2009-8-21] CPGJ was awarded the Leader & Contributor of Science and Technology in the 10th Anniversary of Focus in Zhangjiang Selection Activity
[2009-6-23] YISAIPU: Top 10 Innovations
[2009-5-30] Model Unit
[2009-5-12] National Research Centre of Antibody Drugs Settles in Zhangjiang
[2009-3-6] Shen Investigates CPGJ
[2009-1-16] Continuous Innovation, Developing Together
[2008-12-17] Li Visits CPGJ
[2008-11-26] Delegation from Yunnan Province Visit CPGJ
[2008-11-17] Intellectual Property Investigation & Study
[2008-10-22] Shanghai CP Guojian Pharmaceutical Co. Ltd. attended 10th National High Technology Industrialization Achievement Exhibition
[2008-9-26] Chinese national engineering research center for antibody drugs is approved for construction
[2008-8-6] Annual award of outstanding achievement in science and technology development and annual award of industry model of intellectual property protection of Zhangjiang Hi-tech Park 2007 were given to our company
[2008-5-20] The 13th national RA conference
[2008-5-5] Our Company convened the clinical seminar of new tumor drug on 27th April, 2008
[2008-3-27] YI Luan Chao, member of the CPC Central Committee Politburo, secretary of the CPC Central Committee Secretariat and Minister of Organization visited the company on 21st March 2008.
[2008-3-4] the delegation of Penn EMTM program paid a visit to the company
[2008-4-21] Example Project “Industrialization of high technology of humanized monoclonal antibody drug such as Recombinant Human Tumor Necrosis Factor – a Receptor II: IgG Fc Fusion Protein for Injection” passed acceptance check
[2008-1-14] Three SBI titles won by the Company
First Prev Next Last Page 1 / 3

  Copyright 2002-2006 Shanghai CP Guojian Pharmaceutical Co.,Ltd.